drugset / Trial / NCT00328965
Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study was designed to evaluate the anti-hypertensive efficacy of lacidipine in hypertensives with Type 2 diabetes and effectiveness on endothelial cell function in Korean population.
Timeline
- Start
- 2004-11
- Primary completion
- 2006-05
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacidipine | Small molecule | 6 mg | — |